SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?

被引：0

作者：

Alexander, James L. ^{[1
,2
]}

Powell, Nick ^{[1
,2
]}

机构：

[1] Imperial Coll London, Dept Metab Digest & Reprod, London, England

[2] Imperial Coll Healthcare NHS Trust, Dept Gastroenterol, London, England

来源：

LANCET GASTROENTEROLOGY & HEPATOLOGY | 2021年 / 6卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S28 / S29

页数：3

共 7 条

[1] SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement [J].

Alexander, James L. ;

Moran, Gordon W. ;

Gaya, Daniel R. ;

Raine, Tim ;

Hart, Ailsa ;

Kennedy, Nicholas A. ;

Lindsay, James O. ;

MacDonald, Jonathan ;

Segal, Jonathan P. ;

Sebastian, Shaji ;

Selinger, Christian P. ;

Parkes, Miles ;

Smith, Philip J. ;

Dhar, Anjan ;

Subramanian, Sreedhar ;

Arasaradnam, Ramesh ;

Lamb, Christopher A. ;

Ahmad, Tariq ;

Lees, Charlie W. ;

Dobson, Liz ;

Wakeman, Ruth ;

Iqbal, Tariq H. ;

Arnott, Ian ;

Powell, Nick .

LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (03) :218-224

[2] Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study [J].

Grainge, Matthew J. ;

West, Joe ;

Card, Timothy R. .

LANCET, 2010, 375 (9715) :657-663

[3]

Kennedy NA, 2021, GUT

[4]

MHRA, GREEN BOOK

[5] Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? [J].

Miehsler, W ;

Reinisch, W ;

Valic, E ;

Osterode, W ;

Tillinger, W ;

Feichtenschlager, T ;

Grisar, J ;

Machold, K ;

Scholz, S ;

Vogelsang, H ;

Novacek, G .

GUT, 2004, 53 (04) :542-548

[6]

Pottegard A, BMJ-BRIT MED J, V373, pN1114

[7]

Taquet M., Cerebral Venous Thrombosis: A Retrospective Cohort Study of 513284 Confirmed COVID-19 Cases and a Comparison with 489871 People Receiving a COVID-19 mRNA Vaccine.

← 1 →